CSF UCHL1 levels have been reported to be lower in PD patients compared to controls [4], with the authors hypothesizing that the reduction of UCHL1 in CSF occurs as a consequence of intraneuronal accumulation and deposition of UCHL1 associated with α-synuclein in cortical Lewy bodies. This evidence concerns the gene SNCA and Parkinson disease.